State Key Laboratory for Quality Ensurance and Sustainable Use of Dao-di Herbs, Artemisinin Research Center, and Institute of Chinese Materia Medica, China Academy of Chinese Medical Sciences, Beijing, 100700, China.
School of Pharmacy, Yantai University, No. 30, Qingquan Road, Laishan District, Yantai, Shandong, China.
J Nanobiotechnology. 2024 Jan 8;22(1):24. doi: 10.1186/s12951-023-02235-0.
The iron oxide nanoparticles (IONPs), possessing both magnetic behavior and semiconductor property, have been extensively used in multifunctional biomedical fields due to their biocompatible, biodegradable and low toxicity, such as anticancer, antibacterial, cell labelling activities. Nevertheless, there are few IONPs in clinical use at present. Some IONPs approved for clinical use have been withdrawn due to insufficient understanding of its biomedical applications. Therefore, a systematic summary of IONPs' preparation and biomedical applications is crucial for the next step of entering clinical practice from experimental stage. This review summarized the existing research in the past decade on the biological interaction of IONPs with animal/cells models, and their clinical applications in human. This review aims to provide cutting-edge knowledge involved with IONPs' biological effects in vivo and in vitro, and improve their smarter design and application in biomedical research and clinic trials.
氧化铁纳米颗粒(IONPs)具有磁性和半导体特性,由于其具有生物相容性、可生物降解性和低毒性,如抗癌、抗菌、细胞标记等活性,因此被广泛应用于多功能生物医学领域。然而,目前临床上使用的 IONPs 很少。由于对其生物医学应用的了解不足,一些已批准用于临床的 IONPs 已被撤回。因此,系统总结 IONPs 的制备和生物医学应用对于从实验阶段进入临床实践的下一步至关重要。本综述总结了过去十年中关于 IONPs 与动物/细胞模型的生物相互作用及其在人体中的临床应用的现有研究。本综述旨在提供涉及 IONPs 体内和体外生物效应的最新知识,并改善其在生物医学研究和临床试验中的更智能设计和应用。
J Nanobiotechnology. 2024-1-8
Expert Opin Ther Pat. 2022-9
Biotechnol Appl Biochem. 2022-4
ACS Appl Mater Interfaces. 2025-8-6
Int J Mol Sci. 2025-6-17
Nanomaterials (Basel). 2025-4-29
Pharmaceutics. 2025-4-9
Trends Biotechnol. 2023-12
Cell Death Discov. 2023-6-28
Int J Biol Macromol. 2023-6-30
Am J Cancer Res. 2023-2-15